DR. SHARPE & PARTNERS
RIVERSIDE PRACTICE, RIVERSIDE PRACTICE, PORTADOWN HEALTH&CARE CENTRE, TAVANAGH AVENUE, PORTADOWN, CRAIGAVON
PP 1
In those patients with a new diagnosis of hypertension (excluding those with pre-existing CHD, diabetes, stroke and/or TIA) recorded between the preceding 1 April to 31 March: the percentage of patients who have had a face to face cardiovascular risk assessment at the outset of diagnosis using an agreed risk assessment treatment tool.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| PP 1 | 2010 | 32 | 34 | 94.1% | |
| PP 1 | 2011 | 38 | 53 | 71.7% | |
| PP 1 | 2012 | 30 | 38 | 78.9% | |
| PP 1 | 2013 | 33 | 40 | 82.5% | |
| CVD-PP011NI | 2015 | 45 | 48 | 93.8% | |
| CVD-PP011NI | 2016 | 46 | 50 | 92.0% | |
| CVD-PP011NI | 2017 | 61 | 68 | 89.7% | |
| CVD-PP011NI | 2018 | 38 | 41 | 92.7% | |
| CVD-PP011NI | 2019 | 52 | 55 | 94.5% | |
| CVD-PP011NI | 2020 | 80 | 81 | 98.8% | |
| CVD-PP011NI | 2021 | 30 | 31 | 96.8% |
